Prostate Cancer Clinical Trial
Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure
Summary
The purpose of this phase II, randomized, double-blind placebo controlled, multi-center study is to evaluate the safety and efficacy of 10 mg atrasentan in hormone naive subjects as measured by rate of rise in the PSA (primary objective).
Eligibility Criteria
Inclusion Criteria:
prostate adenocarcinoma,
radical prostatectomy,
PSA between 0.4 and 5 ng/mL,
PSADT < 1 year
Exclusion Criteria:
previous hormonal therapy,
salvage therapy to the pelvis within 3 months prior to randomization
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 39 Locations for this study
Homewood, Alabama, 35205, United States
Anchorage Alaska, 99508, United States
Little Rock Arkansas, 72205, United States
La Mesa California, 91942, United States
Torrance California, 90505, United States
Washington District of Columbia, 20007, United States
Fort Myers Florida, 33916, United States
Tallahassee Florida, 32308, United States
Chicago Illinois, 60611, United States
Baltimore Maryland, 21231, United States
Las Vegas Nevada, 89109, United States
Reno Nevada, 89502, United States
Reno Nevada, 89511, United States
Charlotte, North Carolina, 28204, United States
Cleveland Ohio, 44195, United States
Tulsa, Oklahoma, 74104, United States
Eugene Oregon, 97401, United States
Lancaster Pennsylvania, 17604, United States
Pittsburgh Pennsylvania, 15232, United States
West Reading, Pennsylvania, 19611, United States
West Reading Pennsylvania, 19611, United States
Dallas Texas, 75230, United States
Salt Lake City Utah, 84124, United States
Seattle, Washington, 98166, United States
Seattle Washington, 98195, United States
Calgary, Alberta, T2N 4, Canada
Edmonton Alberta, T6G1Z, Canada
Surrey British Columbia, V3V 1, Canada
Victoria British Columbia, , Canada
Kentville Nova Scotia, B4N4K, Canada
Barrie Ontario, L4M 4, Canada
Burlington Ontario, L7N 3, Canada
Hamilton, Ontario, L8N 1, Canada
London Ontario, N6A 4, Canada
Markham Ontario, L6B1A, Canada
North Bay Ontario, P1B4Z, Canada
North York Ontario, M6A 3, Canada
Oakville Ontario, L6H 3, Canada
Toronto Ontario, M4N 3, Canada
Montreal Quebec, H2L 4, Canada
Quebec , G1R 2, Canada
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.